Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets (2023)
- Authors:
- USP affiliated authors: TROSSINI, GUSTAVO HENRIQUE GOULART - FCF ; FERRAZ, WÍTOR RIBEIRO - FCF ; PENTEADO, ANDRÉ BERNDT - FCF
- Unidade: FCF
- DOI: 10.1080/14728222.2023.2264512
- Subjects: DOENÇA DE CHAGAS; MEDICAMENTO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Expert Opinion on Therapeutic Targets
- ISSN: 1744-7631
- Volume/Número/Paginação/Ano: v. 27, p. 911-925, 2023
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
SOUZA, Mariana Laureano de et al. Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets. Expert Opinion on Therapeutic Targets, v. 27, p. 911-925, 2023Tradução . . Disponível em: https://dx.doi.org/10.1080/14728222.2023.2264512. Acesso em: 01 abr. 2026. -
APA
Souza, M. L. de, Lapierre, thibault J. W. J. D., Marques, G. V. de L., Ferraz, W. R., Penteado, A. B., Trossini, G. H. G., et al. (2023). Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets. Expert Opinion on Therapeutic Targets, 27, 911-925. doi:10.1080/14728222.2023.2264512 -
NLM
Souza ML de, Lapierre thibault JWJD, Marques GV de L, Ferraz WR, Penteado AB, Trossini GHG, Murta SMF, Oliveira RB de, Rezende Junior C de O, Ferreira RS. Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets [Internet]. Expert Opinion on Therapeutic Targets. 2023 ; 27 911-925.[citado 2026 abr. 01 ] Available from: https://dx.doi.org/10.1080/14728222.2023.2264512 -
Vancouver
Souza ML de, Lapierre thibault JWJD, Marques GV de L, Ferraz WR, Penteado AB, Trossini GHG, Murta SMF, Oliveira RB de, Rezende Junior C de O, Ferreira RS. Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets [Internet]. Expert Opinion on Therapeutic Targets. 2023 ; 27 911-925.[citado 2026 abr. 01 ] Available from: https://dx.doi.org/10.1080/14728222.2023.2264512 - Molecular modeling and structural comparison of Leishmania sirtuin 2 enzymes, an epigenetic target in drug discovery
- Structure-Based Virtual Screening: Successes and Pitfalls
- Computational modeling of bradykinin (BK) potentiation by the Ts14 toxin, present in the venom of the scorpion Tityus serrulatus
- Binding evolution of the dengue virus envelope against DC-SIGN: a combined approach of Phylogenetics and molecular dynamics analyses over 30 years of dengue virus in Brazil
- The Red Queen hypothesis from a structural perspective: a case study over 30 years of Dengue virus in Brazil
- New drug discovery strategies for the treatment of Benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease
- Convergent QSAR models for the prediction of Cruzain inhibitors
- Estudo de relação quantitativa entre estrutura química e atividade biológica para propriedades farmacocinética
- Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus
- Modelagem de interação proteína-proteína (PPI) de potencialização da bradicinina pela Toxina Ts14, presente no veneno do escorpião Tityus serrulatus
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
